Mainstream

Xometry beats top-line and bottom-line estimates; initiates Q3 and raises FY25 outlook

Xometry beats top-line and bottom-line estimates; initiates Q3 and raises FY25 outlook

Post ContentxmtrRead More

You might also be interested in reading AtriCure raises 2025 revenue outlook to $527M-$533M with strong Q2 growth and innovation milestones.

August 5, 2025
In Mainstream